Drawing for MANDOS HEALTH

USPTO serial 97178329

MANDOS HEALTH

Reviewed by CopyMark Law Group

Status 814Office Action
Filing date
Status date
Registration date
—
Examiner
SNYDER, NELSON B
Law office
TMEG LAW OFFICE 107

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Need help with MANDOS HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ben Natter

Ben Natter Haug Partners, LLP745 Fifth AvenueNew York, NY 10151United States

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the prevention and treatment of a variety of ailments and conditions, namely, acute bronchitis, allergies, arthritis, asthma, cancer, cellulitis, cirrhosis, common cold, cold sore, conjunctivitis, cystitis, diabetes, diarrhea, ear infection, fever, fibromyalgia, fungal infection, gastroenteritis, headaches, hemorrhoids, high cholesterol, hyperglycemia, hypoglycemia, indigestion, irritable bowel syndrome, influenza, laryngitis, lyme disease, meningitis, mononucleosis, osteoporosis, pneumonia, pyelonephritis, rosacea, sinusitis, skin abscess, stomach aches, and streptococcal pharyngitisACTIVE—
010Medical devices for the purposes of lowering cholesterolACTIVE—
036Business brokerage services and related consulting pertaining to business sales, mergers, acquisitions and business valuations; Intellectual property venture fund management services; Holding company services performed for third parties, namely, investment managementACTIVE—
045Licensing of intellectual propertyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 8, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 8, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 7, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 2, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 2, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 7, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 7, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 7, 2026CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 9, 2026IUAFUSE AMENDMENT FILED—
Mar 9, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 13, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 12, 2025EX5GSOU EXTENSION 5 GRANTED—
Nov 12, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 8, 2025EXT5SOU EXTENSION 5 FILED—
Sep 8, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 8, 2025EX4GSOU EXTENSION 4 GRANTED—
Jul 17, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 17, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 17, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 17, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 17, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 7, 2025EXT4SOU EXTENSION 4 FILED—
Mar 7, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 9, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 9, 2024EX3GSOU EXTENSION 3 GRANTED—
Sep 9, 2024EXT3SOU EXTENSION 3 FILED—
Sep 9, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 17, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 16, 2024EX2GSOU EXTENSION 2 GRANTED—
Feb 16, 2024EXT2SOU EXTENSION 2 FILED—
Feb 16, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 28, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 28, 2023NOACCORRECTED NOA E-MAILED—
Sep 27, 2023EX1GSOU EXTENSION 1 GRANTED—
Sep 27, 2023DPCCDIVISIONAL PROCESSING COMPLETE—
Sep 18, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 7, 2023EXT1SOU EXTENSION 1 FILED—
Sep 7, 2023DRRRDIVISIONAL REQUEST RECEIVED—
Sep 7, 2023ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Sep 7, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 7, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 10, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 10, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 21, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 7, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 7, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Dec 7, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 7, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 7, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 9, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 9, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 9, 2022ALIEASSIGNED TO LIE—
Sep 26, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 23, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2022DOCKASSIGNED TO EXAMINER—
Jan 20, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 20, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 20, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 22, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 21, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance